NEWS

REINSTATING EUROPE AS A GLOBAL HUB FOR ESSENTIAL MEDICINES

26/02/2021

The European medicines supply chain currently depends for more than 74% on supplies sourced from Asia. As witnessed during the Covid-19 outbreak, this puts European healthcare systems at risk” was one of the messages shared by representatives of the European Fine Chemicals Group (EFCG), a sector group of Cefic, at the European Commission’s kick-off meeting of the structured dialogue on the EU Pharmaceutical Strategy on 26 February 2021.

read more

Window of opportunity to enhance EU regulatory systems wide open as EU pharma strategy prioritises stronger EU networks

19/01/2021

The recently published EU pharmaceutical strategy is a welcome tool to address public health challenges in Europe, including equitable access to medicines, reducing medicines shortages, and supporting secure supply chains.

read more

The new Pharmaceutical Strategy for Europe is an opportunity to regain the european supply of Active Pharmaceutical Ingredients according to AFAQUIM

30/11/2020

The European Commission presented last Wednesday the European Pharmaceutical Strategy, a series of proposals with which Brussels aims to boost the level of competitiveness in biopharmaceutical innovation and drug delivery in the continent.

read more

The Hospital of Sant Celoni receives a donation from the UQUIFA company

23/11/2018

The award ceremony of a € 3,000 check that UQUIFA has given to the institution and will be used to finance an electrocardiogram was held at Sant Celoni Hospital on Thursday.

read more

Bioiberica presented four research projects at the Osteoarthritis World Congress

27/04/2018

The meeting was held on 26-29 April 2018 in Liverpool, UK. A study, made in cooperation with FC Barcelona, found new action mechanisms of chondroitin sulfate and glucosamine. The company also presented updates on the use of biomaterials for cartilage regeneration, the development of predictive patterns for the treatment’ response, and the impact of self-care in osteoarthritis patients.

read more

Spray Drying for Highly Potent Drugs

26/04/2018

Idifarma has announced new GMP spray drying capabilities which will make it one of the very few contract development and manufacturing organisations (CDMO) to offer spray drying technology for highly potent drugs up to Category 4 OEL/OEB.

read more

Qualigen launches Rosuvastatin to treat high cholesterol and to prevent cardiovascular disease

26/04/2018

Qualigen launches Rosuvastatina 5 mg, 10 mg and 20 mg film-coated tablets EFG.

read more
This website uses cookies, both own and third parties to collect statistical information about navigation and show advertising related to your preferences, generated from their navigation patterns. If you continue to browse, consider accepting its use. You can change the settings or get more information on cookies here.